The antisaccade task can be used to test the voluntary control of saccadic
eye movements (SEMs). In many disorders with postulated hyperdopaminergic n
eurotransmission, there are reports of abnormalities in SEMs. To further in
vestigate this, the role of dopamine in SEMs, performance on an antisaccade
task was examined in subjects with a history of amphetamine use (a dopamin
e releaser and reuptake inhibitor). A prospective design was employed in a
teaching hospital setting. Six subjects (five males) with a history of amph
etamine use were compared to 24 normal controls. None of the subjects were
using any other substances, except alcohol and nicotine, as determined by u
rine screening, which we believe limited the sample size. For subjects who
used amphetamine before the task, the presence of amphetamine was confirmed
by urinalysis. All subjects completed the antisaccade task. Both error rat
es and latency rates during the antisaccade task were compared between the
amphetamine users and controls. The amphetamine users had significantly inc
reased error rates and latencies. These results may suggest that increased
error rates and latencies during antisaccade tasks may be due to increased
dopamine transmission, which is similar to the findings in schizophrenia.